Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency--a study on 73 subjects from 14 Swiss families.
about
Defective thrombus formation in mice lacking coagulation factor XIIGenetics of ischaemic stroke in young adultsCoagulation and the vessel wall in pulmonary embolismFactor XI and contact activation as targets for antithrombotic therapyHageman factor, platelets and polyphosphates: early history and recent connectionFactor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study.Combined cis-regulator elements as important mechanism affecting FXII plasma levelsIn vivo roles of factor XII.Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation.Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsisFactor XII inhibition reduces thrombus formation in a primate thrombosis model.Factors XI and XII as Targets for New Anticoagulants.Factor XI and XII as antithrombotic targets.The role of coagulation/fibrinolysis during Streptococcus pyogenes infection.The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy.Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.The Effects of the Contact Activation System on Hemorrhage.Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.
P2860
Q24646366-91F6671A-4F08-4869-A0C4-102EB8CDDC57Q26775633-02D75CC8-D35F-4AAA-8005-079CD27385C0Q27021049-8933C787-B03A-49EF-9B87-50D36B9C6BEEQ27024190-58507045-2E49-4EAA-94DE-E5E1C57161B5Q28748668-8D24EDB1-B978-40D6-A0CC-099FD969313AQ33706174-A52987D6-FA6A-4120-BA9D-7BCBCAA21E38Q34003352-B1DEDD09-54ED-4DD0-84D5-99FCBC06F68BQ34300714-2FB60D9D-311A-4931-A76D-C1074801D761Q35800631-07594F53-EE95-46D4-8683-F83199BBD728Q36010211-3CD30684-3402-4BED-B4AA-6C0F9DE1DA23Q37636983-A1C9EB20-BC43-4FEE-BA69-625B0F985C74Q37662547-BB03E9DD-41E7-4D51-999C-A0DF74DF4657Q37897854-9D3B8F22-DF7C-4812-8FB3-964B87E5C67BQ38259589-5BA56A69-E5B5-4A05-8F64-1F7659826E6CQ38956551-B8952E2E-E556-4B2A-9593-57A848447B1BQ40470385-694022D3-7941-4980-A21C-0C8FB2BFEE13Q41171782-D3E5F4B1-FA76-4FA8-95C4-0E0E5FD59F4FQ55052361-E1FDA4D3-3CEB-4DDF-8143-FD9DDDA9185E
P2860
Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency--a study on 73 subjects from 14 Swiss families.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Reevaluation of the incidence ...... bjects from 14 Swiss families.
@en
Reevaluation of the incidence ...... bjects from 14 Swiss families.
@nl
type
label
Reevaluation of the incidence ...... bjects from 14 Swiss families.
@en
Reevaluation of the incidence ...... bjects from 14 Swiss families.
@nl
prefLabel
Reevaluation of the incidence ...... bjects from 14 Swiss families.
@en
Reevaluation of the incidence ...... bjects from 14 Swiss families.
@nl
P2093
P1476
Reevaluation of the incidence ...... ubjects from 14 Swiss families
@en
P2093
Schloesser M
Wuillemin WA
Zeerleder S
P304
P577
1999-10-01T00:00:00Z